Evidence map›Paper›PMID 36154359›Full record

ArticleJournal of bacteriology2022

Functional

James Lee, Miguel Carda-Diéguez, Miglė Žiemytė, Sarah Vreugde, Clare Cooksley, Heidi A Crosby, Alexander R Horswill, Alex Mira, Peter S Zilm, Stephen P Kidd

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of bacteriology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Microorganisms · 2025
    Review
  3. Article
  4. Subpopulations in Strains ofAntibiotics (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

James LeeDepartment of Molecular and Biomedical Sciences, School of Biological Sciences, The University of Adelaidegrid.1010.0, Adelaide, South Australia, Australia.
Miguel Carda-DiéguezDepartment of Health and Genomics, Center for Advanced Research in Public Health, FISABIO Foundation, Valencia, Spain.
Miglė ŽiemytėDepartment of Health and Genomics, Center for Advanced Research in Public Health, FISABIO Foundation, Valencia, Spain.
Sarah VreugdeDepartment of Otolaryngology, Head and Neck Surgery, Basil Hetzel Institute, South Australia, Adelaide, Australia.
Clare CooksleyDepartment of Otolaryngology, Head and Neck Surgery, Basil Hetzel Institute, South Australia, Adelaide, Australia.
Heidi A CrosbyDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Alexander R HorswillDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.ORCID 0000-0002-5568-0096
Alex MiraDepartment of Health and Genomics, Center for Advanced Research in Public Health, FISABIO Foundation, Valencia, Spain.
Peter S ZilmAdelaide Dental School, The University of Adelaidegrid.1010.0, Adelaide, South Australia, Australia.
Stephen P KiddDepartment of Molecular and Biomedical Sciences, School of Biological Sciences, The University of Adelaidegrid.1010.0, Adelaide, South Australia, Australia.ORCID 0000-0002-2118-1651
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESThe University of Adelaide · AUBasil Hetzel Institute · AUUniversity of Colorado Denver · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prolonged survival in the host-bacteria microenvironment drives the selection of alternative cell types in Staphylococcus aureus, permitting quasi-dormant sub-populations to develop. These facilitate antibiotic tolerance, long-term growth, and relapse of infection. Small Colony Variants (SCV) are an important cell type associated with persistent infection but are difficult to study

Indexed as

Staphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsDNAHumansRecombinasesRecurrenceTranscription FactorsTyrosineAnti-Bacterial AgentsDNARecombinasesTranscription FactorsTyrosinepersistenceSmall Colony VariantsStaphylococcus aureus

Identifiers

PMID36154359
PMCPMC9578419
OpenAlexW4297255965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.